Widespread Molecular Alterations Present in Stage I Non-Small Cell Lung Carcinoma Fail to Predict Tumor Recurrence
- 1 January 2003
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 16 (1) , 28-34
- https://doi.org/10.1097/01.mp.0000044621.08865.c4
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinomaOncogene, 1999
- Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinomaOncogene, 1999
- p53 Mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinomaCancer, 1999
- Prognostic value of loss of heterozygosity and KRAS2 mutations in lung adenocarcinomaInternational Journal of Cancer, 1998
- Cloning of a human homolog of the yeast OGG1 gene that is involved in the repair of oxidative DNA damageOncogene, 1997
- Sequence Analysis of Two Genomic Regions Containing the KIT and the FMS Receptor Tyrosine Kinase GenesGenomics, 1997
- Angiogenesis and molecular biologic substaging in patients with stage I non—small cell lung cancerThe Annals of Thoracic Surgery, 1996
- Detailed deletion mapping of chromosome segment 17q12‐21 in sporadic breast tumoursGenes, Chromosomes and Cancer, 1994
- p53, guardian of the genomeNature, 1992
- The Effect of Surgical Treatment on Survival from Early Lung CancerChest, 1992